WHO Report on HIV, Hepatitis, and STI Response Progress 2022-2030

WHO Global Health Sector Strategies Progress Report

The World Health Organization released a comprehensive progress report evaluating implementation of the Global Health Sector Strategies (GHSS) on HIV, viral hepatitis, and sexually transmitted infections (STIs) for the 2022–2030 period. This report was launched during the 26th International AIDS Conference (AIDS 2026) and coincides with World Hepatitis Day on July 28.

Key Focus Areas

The report emphasizes three pillars identified as essential to ending these epidemics:

  • Integration: Coordinated healthcare responses across HIV, hepatitis, and STI services
  • Innovation: Implementation of new diagnostic tools, treatment modalities, and prevention strategies
  • Community Leadership: Engagement of affected populations in disease response and policy development

Significance for Travelers

While this report addresses global public health policy rather than specific destination-based health alerts, international travelers should recognize that:

  • HIV, hepatitis B and C, and STIs remain health considerations in many destinations
  • Vaccination status (particularly hepatitis A and B) should be reviewed before international travel
  • Access to preventive services and testing varies by country
  • Pre-travel consultation with a healthcare provider is recommended for comprehensive protection planning

Progress and Persistent Challenges

The WHO report acknowledges both achievements in global disease response and remaining barriers to elimination. The integration of services across these conditions reflects evolving public health approaches to interconnected epidemics.

Pharmacist's note: As a healthcare professional, I recommend that travelers consult with their primary care provider or a travel medicine specialist 4-6 weeks before departure to review individual risk factors, vaccination status, and preventive strategies. While this WHO report addresses global health policy, it underscores the importance of being informed about disease prevention in destination countries. Travelers should maintain access to current information about healthcare resources at their destination and understand their own health status relative to these conditions.

Primary sources

PharmTrip may include promotional content. Products and services are independently evaluated by a licensed pharmacist and rankings are never altered by advertiser requests. Information reflects what was current at the time of writing — please verify the latest terms on each provider's official site.